# SprintRay

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sprintray

- Industry: Healthcare Specialists
- Headquarters: Los Angeles, US
- Website: www.sprintray.com
- Total disclosed funding: $114M
- Latest round: Series D (Oct 10, 2022)
- Investors on record: 8

## About

Based in California, US, and founded in 2014, SprintRay Inc. manufactures 3D printers for digital dentistry. In October 2022, the firm raised USD 100 million in Series D funding led by investor SB Investment Advisers, with participation from other investors Yiheng Capital and ZWC Ventures. Returning investors CD Capital and Marathon Venture Partners also participated in the round. The company was co-founded by Amir Mansouri (CEO) and Jing Zhang (CTO).

The company offers a wide range of 3D printing products such as dental 3D printers, RayWare cloud, RayWare desktop, pro-wash/dry, and procure 2. Additionally, the firm provides 3D printing materials which include SprintRay Materials, and partners’ materials. Furthermore, the firm also provides SprintRay dashboard, cloud-based designing software, and post-processing machines for dental professionals which enable them to design and develop custom dental implants for their patients.

The company plans to use the October 2022 funding to expand its business beyond its traditional US and European markets to generate more sales in Southeast Asia.

## Funding rounds

- Series D, Oct 10, 2022, $100M — CD Capital, Yiheng Capital, Marathon Venture Partners, SB Investment Advisers, ZWC Ventures
- Series C, Nov 10, 2020 — Shanghai Jianyi Private Equity Fund Management, Kunlun Group Limited, China Life Capital
- Series B, Oct 1, 2019, $14M — CD Capital, Marathon Venture Partners

## Investors

- CD Capital — Series B, Series D
- Marathon Venture Partners (https://capitalatlas.ai/funds/marathon-venture-partners) — Series B, Series D
- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Series C
- Kunlun Group Limited — Series C
- China Life Capital — Series C
- Yiheng Capital — Series D
- SB Investment Advisers (https://capitalatlas.ai/funds/sb-investment-advisers) — Series D
- ZWC Ventures (https://capitalatlas.ai/funds/zwc-ventures) — Series D